【brief interviews with hideous men pdf】Boston Scientific to Sell ZelanteDVT Catheter in US, Europe
Boston Scientific Corporation
BSX recently won the U.S. Food and Drug Administration’s (FDA) approval and the CE Mark for its AngioJet ZelanteDVT thrombectomy catheter. Thebrief interviews with hideous men pdf regulatory clearances make way for the commercialization of the device in the U.S. and European markets, respectively. Notably, the ZelanteDVT catheter specifically aims at curing deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins.
We believe the receipt of these landmark approvals with respect to two key markets will allow this medical technology giant to further bolster its footprint in the global clot management devices market.
DVT, a medical condition involving formation of blood clots in one or more of the deeper veins, often remains underdiagnosed and may lead to serious complications; if not cured at an earlier stage. The most serious complication of DVT occurs when part of the clot breaks off and travels through the bloodstream to the lungs, causing a blockage called pulmonary embolism (PE). In the event of large clots, such complications may actually be fatal for patients.
As per the estimates of the Centers for Disease Control and Prevention (CDC), every year, as many as 900,000 people are potentially affected by DVT/PE in the U.S. alone. Moreover, almost 60,000-100,000 Americans die of these conditions. Such a huge prospective patient pool thus indicates strong scope for Boston Scientific’s ZelanteDVT catheter.
In most of the cases, physicians advise oral as well as injectable anticoagulant drugs to treat DVT/PE. However, as these drugs reduce the ability of blood to clot in a patient, they may cause unusual bleeding. That is why, as a therapeutic alternative, surgeons often perform interventional procedures to remove or break up a clot in DVT patients.
Boston Scientific’s ZelanteDVT is the most powerful thrombectomy catheter in the company’s current market-leading AngioJet portfolio, designed to efficiently remove large venous clots and facilitate rapid restoration of blood flow. Per management, this device potentially reduces the procedural time of removing clots; thereby mitigating complications caused due to delayed treatment.
This apart, the ZelanteDVT catheter also helps control bleeding risks. This reduces the need for future hospitalization, thus saving on costs that are unwarrantedly incurred in the context of this challenging condition.
With the global clot management devices market expected to grow at a CAGR of 5.9% during the period 2014–2019, the aforementioned regulatory approvals in the U.S. and European markets comes in handy for Boston Scientific. Based on these, the company is poised to capture a larger share of this growing market potential, going ahead.
Story continues
Zacks Rank
Currently, the company carries a Zacks Rank #3 (Hold). Some better-ranked medical products stocks are GW Pharmaceuticals plc GWPH, Hill-Rom Holdings, Inc. HRC and ICU Medical, Inc. ICUI. All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
GW PHARMA-ADR (GWPH): Free Stock Analysis Report
HILL-ROM HLDGS (HRC): Free Stock Analysis Report
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
(责任编辑:Entertainment)
- GE Aviation Furloughs Half Its Engine Manufacturing Workforce Amid Coronavirus Pandemic
- The Best Places in Every State To Live on a Fixed Income
- Romios Completes 2020 Field Work in the Golden Triangle, Identifies Strong Alteration Zones at Recent Copper-Gold Discoveries on its TREK SOUTH and ANDREI EAST Porphyry Targets
- PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
- Global Vision Care Market (2020 to 2025) - Featuring Alcon, Carl Zeiss and Hoya Among Others
- Hedge Funds Souring On E*TRADE Financial (ETFC)
- Does ICC Holdings, Inc.'s (NASDAQ:ICCH) CEO Pay Reflect Performance?
- Despite Its High P/E Ratio, Is Ovzon AB (publ) (STO:OVZON) Still Undervalued?
- Is AquaBounty Technologies (NASDAQ:AQB) Using Too Much Debt?
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Opera Limited (OPRA) Investors With Losses to Contact its Attorneys: Important Class Action Deadline Approaching
- Camber Energy, Inc. and Viking Energy Group, Inc. Amend Definitive Merger Agreement Relating to Their Planned Combination and Provide Update on Status of Merger
- Rand Capital Corp. to Host Earnings Call
- 5 High-Yield Stocks to Defy Coronavirus-Led Crisis in April
-
Looking at Q3,Facebook(NASDAQ:FB) earned $8.04 billion, a 34.83% increase from the preceding quarter ...[详细]
-
Sanoma Oyj: Managers' Transactions
SANOMA OYJ MANAGERS' TRANSACTIONS 5 NOVEMBER 2020Sanoma Oyj - Managers' Transactions________________ ...[详细] -
Petrolympic Announces Closing of Private Placement
TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Petrolympic Ltd. (the "Company") (TSX-V:PCQ – OTCQB:PCQRF ...[详细] -
Americans have a mix of concern and hope about the economy
Get all the latest news on coronavirus and more delivered daily to your inbox.Sign up here.The prese ...[详细] -
EMERGING MARKETS-Latam FX attempt comeback, Colombian peso eyes best day in 7 months
* Colombian peso gains as oil prices surge * Brazil 2020 growth, FX outlook slip to new lows - cenba ...[详细] -
Were Hedge Funds Right About Automatic Data Processing (ADP)?
We hate to say this but, we told you so. On February 27th we published an article with the titleRece ...[详细] -
IBM Stock Falls 4%Investing.com - IBM (NYSE:IBM) Stock fell by 4.02% to trade at $128.79 by 15:12 (2 ...[详细]
-
Open enrollment 2021: You may be able to carry over unused FSA funds of up to $550
Open enrollment season is here, which means some of you are running out of time to use your tax-adva ...[详细] -
After Facebook deal, Reliance Jio rakes in $747 million from PE giant Silver Lake
Jio Platforms, the technology arm of India’s most valued company, Reliance Industries (RIL), has rai ...[详细] -
Is Innovative Industrial Properties (IIPR) Stock Outpacing Its Finance Peers This Year?
The Finance group has plenty of great stocks, but investors should always be looking for companies t ...[详细]
- Don't Buy WirTek A/S (CPH:WIRTEK) For Its Next Dividend Without Doing These Checks
- The Global Enterprise Very Small Aperture Terminal (VSAT) Market is expected to grow by $ 1.82 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period
- Thai Airways rescue plan is its last chance, says PM
- Live Oak Acquisition Corp. II Announces Pricing of Upsized $220,000,000 Initial Public Offering
- Company News for Mar 10, 2020
- Big cash holdings in Europe signal unease over stock market outlook
- Teleste's financial reporting and Annual General Meeting in 2021